NEW YORK (Reuters Health) – For patients with advanced HIV disease –either AIDS or a CD4 count below 200 — initial antiretroviral regimens based on efavirenz or ritonavir-boosted…
NEW YORK (Reuters Health) – HIV patients with fully suppressed viral load on standard triple therapy should not be switched to a maintenance regimen of ritonavir-boosted lopinavir monotherapy,…
NEW YORK (Reuters Health) – Determining the low-density lipoprotein particle (LDL-p) concentration in women with HIV doesn’t seem to be worthwhile, as doing so adds little information beyond…
NEW YORK (Reuters Health) – Once a diagnosis of tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) is confirmed in HIV patients being treated with antiretroviral therapy, a course of…
NEW YORK (Reuters Health) – Compared with dual therapy for HIV, highly active antiretroviral therapy (HAART) in pregnant women is associated with an increased risk of preterm delivery,…
NEW YORK (Reuters Health) – A cervical cancer prevention trial conducted in South Africa shows that a single test for human papillomavirus (HPV) infection followed by cryotherapy in…
NEW YORK (Reuters Health) – Rates of clearance of high-grade anal canal intraepithelial neoplasia in men with HIV are improved considerably by topical application of imiquimod cream, a…
NEW YORK (Reuters Health) – Prospective study results suggest that saquinavir is the only older protease inhibitor (PI) not associated with an increased risk of myocardial infarction (MI).…
NEW YORK (Reuters Health) – A South African study shows that HIV-infected patients do better when they begin treatment above rather than below 200 cells/µL. The results, reported…
NEW YORK (Reuters Health) – HIV-positive patients taking efavirenz are at risk for clinically significant vitamin D deficiency, and for excessive bone turnover if they are taking tenofovir,…